4/30
06:08 am
acrv
Form EFFECT Acrivon Therapeutics,
Medium
Report
Form EFFECT Acrivon Therapeutics,
4/26
08:37 am
acrv
Form ARS Acrivon Therapeutics, For: Dec 31
Medium
Report
Form ARS Acrivon Therapeutics, For: Dec 31
4/26
08:34 am
acrv
Form DEFA14A Acrivon Therapeutics,
Medium
Report
Form DEFA14A Acrivon Therapeutics,
4/26
08:30 am
acrv
Form DEF 14A Acrivon Therapeutics, For: Jun 20
Medium
Report
Form DEF 14A Acrivon Therapeutics, For: Jun 20
4/24
04:03 pm
acrv
Form 8-K Acrivon Therapeutics, For: Apr 24
High
Report
Form 8-K Acrivon Therapeutics, For: Apr 24
4/19
04:11 pm
acrv
Form 4 Acrivon Therapeutics, For: Apr 17 Filed by: Miller Mary
Low
Report
Form 4 Acrivon Therapeutics, For: Apr 17 Filed by: Miller Mary
4/17
04:39 pm
acrv
Form S-3 Acrivon Therapeutics,
Low
Report
Form S-3 Acrivon Therapeutics,
4/15
04:16 pm
acrv
Form 4 Acrivon Therapeutics, For: Apr 11 Filed by: Shah Rajeev M.
Low
Report
Form 4 Acrivon Therapeutics, For: Apr 11 Filed by: Shah Rajeev M.
4/15
08:54 am
acrv
Form 4 Acrivon Therapeutics, For: Apr 11 Filed by: PERCEPTIVE ADVISORS LLC
Medium
Report
Form 4 Acrivon Therapeutics, For: Apr 11 Filed by: PERCEPTIVE ADVISORS LLC
4/15
08:22 am
acrv
Form SC 13G/A Acrivon Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SC 13G/A Acrivon Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
4/11
04:16 pm
acrv
Form SC 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SC 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
4/9
07:06 am
acrv
Form 8-K Acrivon Therapeutics, For: Apr 08
Medium
Report
Form 8-K Acrivon Therapeutics, For: Apr 08
3/29
09:06 am
acrv
Form S-8 Acrivon Therapeutics,
Low
Report
Form S-8 Acrivon Therapeutics,
3/28
08:00 am
acrv
Form 8-K Acrivon Therapeutics, For: Mar 28
High
Report
Form 8-K Acrivon Therapeutics, For: Mar 28
3/28
07:39 am
acrv
Form 10-K Acrivon Therapeutics, For: Dec 31
High
Report
Form 10-K Acrivon Therapeutics, For: Dec 31
3/6
04:33 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 04 Filed by: Palani Santhosh
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 04 Filed by: Palani Santhosh
3/6
04:30 pm
acrv
Form 3 Acrivon Therapeutics, For: Mar 04 Filed by: Palani Santhosh
Medium
Report
Form 3 Acrivon Therapeutics, For: Mar 04 Filed by: Palani Santhosh
3/4
08:16 am
acrv
Form 8-K Acrivon Therapeutics, For: Mar 04
High
Report
Form 8-K Acrivon Therapeutics, For: Mar 04
2/16
05:15 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Miller Mary
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Miller Mary
2/16
05:14 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Masson Kristina
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Masson Kristina
2/16
05:13 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Holm-Jorgensen Rasmus
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Holm-Jorgensen Rasmus
2/16
05:11 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Gamelin Erick
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Gamelin Erick
2/16
05:09 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Devroe Eric
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Devroe Eric
2/16
05:07 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Blume-Jensen Peter
Medium
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Blume-Jensen Peter
2/14
04:57 pm
acrv
Form SC 13G/A Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
High
Report
Form SC 13G/A Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC